Business UpdateJun 2, 2026, 08:42 AM
INVO Fertility Acquires Clinic, Faces Nasdaq Delisting Warning
AI Summary
INVO Fertility, Inc. (IVF) filed its 10-K, detailing recent business developments including the acquisition of Family Beginnings, a fertility clinic, for $760,000. The company is facing Nasdaq non-compliance for late filings of its 10-K and 10-Q. Significant corporate actions include a 1-for-5 reverse stock split, a warrant inducement transaction raising $7.5 million, and an increase in authorized shares. The company also settled a litigation with Dr. Elizabeth Pritts for $6 million and divested a majority stake in NAYA Therapeutics.
Key Highlights
- INVO Fertility acquired Family Beginnings, a fertility clinic in Indiana, for approximately $760,000.
- The company received Nasdaq non-compliance letters for failing to file its 10-K and 10-Q on time.
- INVO Fertility completed a 1-for-5 reverse stock split effective March 27, 2026.
- A warrant inducement transaction in January 2026 generated approximately $7.5 million in gross proceeds.
- The company increased authorized common stock from 6,250,000 to 250,000,000 shares in January 2026.
- A private placement in December 2025 raised approximately $4.0 million.
- A settlement agreement was reached with Dr. Elizabeth Pritts for $6,000,000, with initial payment of $525,000.
- The company divested a majority stake in NAYA Therapeutics, Inc. on June 2, 2025.
Price Impact
More from IVF